BEIJING, Sept. 23, 2016 -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of sophisticated data analysis software in China, today announced that its initial public offering of 6,700,000 American depositary shares (“ADSs”) was priced at US$13.00 per ADS, with a total offering size of US$87.1 million, assuming no exercise by the underwriters of their option to purchase additional ADSs. Each ADS represents one Class B ordinary share of the Company. The ADSs are expected to begin trading on the NASDAQ Global Select Market on September 23, 2016 under the symbol “GSUM.”
The Company has granted the underwriters a 30-day option to purchase up to an additional 1,005,000 ADSs at the initial public offering price, less the underwriting discounts and commission.
Goldman Sachs (Asia) L.L.C., Citigroup Global Markets Inc. and Stifel, Nicolaus & Company, Incorporated acted as joint bookrunners for the offering.
Gridsum’s registration statement relating to these securities has been filed with the United States Securities and Exchange Commission and was declared effective on September 22, 2016.
The offering of the securities is made only by means of a prospectus forming a part of the effective registration statement. A copy of the final prospectus relating to the offering may be obtained, when available, by contacting Goldman, Sachs & Co. at 1-212-902-1171, Citigroup Global Markets Inc. at 1-800-285-3000, or Stifel, Nicolaus & Company, Incorporated at 1-415-364-2720.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities, in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Investor Relations: ICR, Inc. Violet Gu Tel: +1 (646) 328-2510 Email: [email protected]


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Instagram Outage Disrupts Thousands of U.S. Users
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



